Peeling Back The Layers: Exploring Oscar Health Through Analyst Insights
Portfolio Pulse from Benzinga Insights
Oscar Health (NYSE:OSCR) has been analyzed by 7 analysts over the past three months, showing a range of perspectives from bullish to bearish. The average 12-month price target has increased by 5.66% to $25.57. Key analysts have adjusted their ratings and price targets, reflecting their views on the company's market performance. Oscar Health has shown strong revenue growth and effective utilization of equity and assets, but faces challenges in maintaining profitability.
August 08, 2024 | 7:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oscar Health has received mixed analyst ratings, with an average 12-month price target of $25.57, up 5.66%. The company shows strong revenue growth and effective use of equity and assets, but faces profitability challenges.
The increase in the average price target and positive revenue growth are likely to boost investor confidence in the short term. However, challenges in profitability may temper some of the enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100